Codman & Shurtleff Report issue

For profit Phase 3
Founded: Randolph MA United States (1838)
Status: Acquired by Integra LifeSciences Corporation (2017)

Organization Overview

First Clinical Trial
2008
NCT00816166
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ischemia (Phase 3)

Ischemic Attack, Transient (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2